Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.
about
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionGenetic and nongenetic risk factors for childhood cancerIonising radiation and cancer risks: what have we learned from epidemiology?Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.Developing strategies for long term follow up of survivors of childhood cancerSecondary malignant neoplasms after Wilms tumor: an international collaborative study.Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaLeukemias related to treatment with DNA topoisomerase II inhibitors.Therapy related leukemias: susceptibility, prevention and treatment.Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy.Late effects of total body irradiation.Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin.Second cancers in survivors of childhood cancer.Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study CohortTreatment of Langerhans cell histiocytosis--evolution and current approaches.Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentAssociation of CYP3A4 genotype with treatment-related leukemia.Long-term population-based risks of second malignant neoplasms after childhood cancer in BritainIs age an independent risk factor for chemically induced acute myelogenous leukemia in children?Secondary malignancies across the age spectrum.Secondary ALL after Successful Treatment of Ewing's Sarcoma: A Case Report.Late effects in childhood cancer survivors: a review with a framing effect bias?Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries.Therapy-related B-lymphoblastic leukemia associated with Philadelphia chromosome and MLL rearrangement: Single institution experience and the review of the literature.Haematologic Malignancy Secondary to the Treatment of Lymphoma.Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.The changing face of paediatric oncology.A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.Retaining personal medical records of children who have had chemotherapy and radiotherapy.Secondary acute lymphoblastic leukaemia in a multiple myeloma patient.Second primary cancers after childhood cancer.Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
P2860
Q24567501-431F78F8-B570-4C18-9FD2-9EFDEA5C38B8Q27693894-D7370B15-4069-4055-8993-E0962F2F78C0Q28395078-70F8C25D-4167-418C-A889-656EC55A2656Q30982315-3FB47005-5B6C-4AB3-981F-47727864E970Q33613662-8B872CD3-BD15-42C4-A248-657EAA3F38BDQ33634367-2E490C74-3091-496B-9FE6-CD02FBCED2F9Q33705736-0315CE67-31C7-4957-963A-5D2B174E468CQ33806580-385F7465-DC3A-4E36-BEA7-DD6EB5A442B9Q33886717-13F1EBDB-8843-40D6-B154-4E79A30D5343Q33943185-297C2380-82BB-4237-9F90-B63AF0820F3AQ34243503-3470864F-721F-4C84-A69C-145050C4CC90Q34265193-2501B2DD-0B43-4E01-9169-895AD23737E8Q34366619-B2920043-7684-4215-A3B7-8E4845CF52DEQ34795945-AD491D42-3A94-4989-8F55-E8AC3926BE89Q34800198-D8695749-207A-465E-8C78-F66117BECBC5Q35084794-22821B41-17E3-4F1F-904C-6A84308F9352Q35628171-F5031333-1205-4423-8036-5AD1C47B9E70Q35661353-13162305-3AB5-42D4-A211-0BA0C86C4BCDQ36211593-A9EC2DF5-FF6F-43AF-9CF2-57767AB8463AQ36291261-CEFE9B9F-E591-4818-BAEE-6C8EC2AF25D3Q36619454-E931C99B-B183-4DCB-B5C1-F8FD35DE8148Q36643196-38A529D5-7AE5-406D-8B27-5C464A93FA34Q36695165-E8779AC9-18B7-4235-AB53-9F811F189E6BQ36905628-E3F2DE34-7D61-4DC4-BFE2-512619AA3880Q37379773-FD97BCDB-9F33-436E-8DFA-E3B8C52CE756Q37477996-51162E5B-02EA-45E3-A3AB-D21F5FBAC9E9Q37831281-3782CA2F-AFB5-4942-8380-4D6C17855ED2Q38495328-30CDADE7-A565-487A-88F7-4B62B468CF85Q38563868-01D3C383-6317-4E84-983D-8E57BA3A8EC7Q38894418-15A9B797-15F2-4278-AA1C-B2F88108A687Q40260616-0BE88966-2BF5-454F-9773-DF5BACD3DAD9Q40427103-466FD936-B449-4CB9-B99C-69011E0D41EBQ40771488-526C97EC-688C-47AD-A176-26D7E3000E8FQ42588366-B5FDBABC-2018-4361-A9A8-7816EFC6C3D4Q43121136-4FEF8D97-BD28-4B85-9C07-7DC7224AFC1FQ43187406-023C4393-C0ED-479B-9234-DA03F1A5E7D8Q44546239-0BD9E552-1332-40C8-BB66-BD3766D9607BQ47435482-62E89B21-C393-48F8-99DB-F9EE62B39E8AQ50963043-EC3083E3-DD08-474F-BD0F-732E45905984Q52330375-3CEF4FAE-FE3F-43AB-BC64-766EC414C1AF
P2860
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@ast
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@en
type
label
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@ast
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@en
prefLabel
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@ast
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@en
P2093
P2860
P356
P1433
P1476
Epipodophyllotoxins, alkylatin ...... kaemia after childhood cancer.
@en
P2093
Chessells JM
Hawkins MM
Kingston JE
Marsden HB
Stovall MA
P2860
P304
P356
10.1136/BMJ.304.6832.951
P407
P577
1992-04-01T00:00:00Z